Intracerebroventricular administration of CXCL12 reduces Aβ deposits in AD mice, which is associated with an increase of cells positive for the microglia marker Iba1, suggesting that CXCL12 recruits migroglia cells to induce Aβ clearance49. This evidence concerns the gene AIF1 and Alzheimer disease.